Mukund Jha

New Delhi, DL 110062, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Identification of novel pyrazole-containing thiazolidine-2,4-dione derivatives as potent α-glucosidase inhibitors: design, synthesis and antidiabetic assessment.

Identification of novel pyrazole-containing thiazolidine-2,4-dione derivatives as potent α-glucosidase inhibitors: design, synthesis and antidiabetic assessment.

Journal: Bioorganic chemistry

Published: February 15, 2026

Heterocyclic GABAA Receptor Modulators: Emerging Therapeutic Strategies for Epilepsy Management.

Heterocyclic GABAA Receptor Modulators: Emerging Therapeutic Strategies for Epilepsy Management.

Journal: Chemistry & biodiversity

Published: July 07, 2025

EGFR-targeted tyrosine kinase inhibitors: advancements in cancer therapy.

EGFR-targeted tyrosine kinase inhibitors: advancements in cancer therapy.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: April 12, 2025

Pyrazole and Pyrazoline-Based EGFR TK Inhibitors: A Review Study Emphasizing Structure-Activity Relationship (SAR).

Pyrazole and Pyrazoline-Based EGFR TK Inhibitors: A Review Study Emphasizing Structure-Activity Relationship (SAR).

Journal: Medicinal chemistry (Shariqah (United Arab Emirates))

Published: December 19, 2024

Triazole scaffold-based DPP-IV Inhibitors for the management of Type-II Diabetes Mellitus: Insight into Molecular Docking and SAR.

Triazole scaffold-based DPP-IV Inhibitors for the management of Type-II Diabetes Mellitus: Insight into Molecular Docking and SAR.

Journal: Current topics in medicinal chemistry

Published: July 24, 2024

Triazole Scaffold-based DPP-IV Inhibitors for the Management of Type-II Diabetes Mellitus: Insight into Molecular Docking and SAR.

Triazole Scaffold-based DPP-IV Inhibitors for the Management of Type-II Diabetes Mellitus: Insight into Molecular Docking and SAR.

Journal: Current topics in medicinal chemistry

Published: July 24, 2024

Insight into Structure Activity Relationship of DPP-4 Inhibitors for Development of Antidiabetic Agents.

Insight into Structure Activity Relationship of DPP-4 Inhibitors for Development of Antidiabetic Agents.

Journal: Molecules (Basel, Switzerland)

Published: May 13, 2023

Recent advancement in the discovery and development of anti-epileptic biomolecules: An insight into structure activity relationship and Docking.

Recent advancement in the discovery and development of anti-epileptic biomolecules: An insight into structure activity relationship and Docking.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: June 03, 2020

Design, Synthesis, Molecular Docking, and Anticancer Evaluation of Pyrazole Linked Pyrazoline Derivatives with Carbothioamide Tail as EGFR Kinase Inhibitors.

Design, Synthesis, Molecular Docking, and Anticancer Evaluation of Pyrazole Linked Pyrazoline Derivatives with Carbothioamide Tail as EGFR Kinase Inhibitors.

Journal: Anti-cancer agents in medicinal chemistry

Published: November 16, 2019

3'-(4-(Benzyloxy)phenyl)-1'-phenyl-5-(heteroaryl/aryl)-3,4-dihydro-1'H,2H-[3,4'-bipyrazole]-2-carboxamides as EGFR kinase inhibitors: Synthesis, anticancer evaluation, and molecular docking studies.

3'-(4-(Benzyloxy)phenyl)-1'-phenyl-5-(heteroaryl/aryl)-3,4-dihydro-1'H,2H-[3,4'-bipyrazole]-2-carboxamides as EGFR kinase inhibitors: Synthesis, anticancer evaluation, and molecular docking studies.

Journal: Archiv der Pharmazie

Published: September 06, 2019

Recent advancement in the discovery and development of COX-2 inhibitors: Insight into biological activities and SAR studies (2008-2019).

Recent advancement in the discovery and development of COX-2 inhibitors: Insight into biological activities and SAR studies (2008-2019).

Journal: Bioorganic chemistry

Published: February 26, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026